A Phase I, First-In-Human Study of CBA-1205, an Anti-DLK1 Monoclonal Antibody, in Patients With Advanced Solid Tumors.

CBA-1205 - Chiome Biosci

http://www.ncbi.nlm.nih.gov/pubmed/39832211

Chihiro Kondoh; Daisuke Kotani; Jun Sato; Kazuo Watanabe; Mao Okada; Masafumi Ikeda; Noboru Yamamoto; Nobuaki Matsubara; Shose Taoka; Takafumi Koyama; Toru Mukohara; Yoshimi Ogawa; Yuki Katsuya

Jan 21, 2025